Forouzan (; 9 August 1937 – 24 January 2016) was an Iranian actress, producer, and dubbing artist. She started her career by voice dubbing. In 1964 she starred in Siamak Yasemi's ""Sahel-e Entezar"" but this was "Ganj-e Qarun", another movie by Yasemi that made her very famous. Her career came to an end because of the Iranian revolution of 1979.
Forouzan died in Tehran, Iran on 24 January 2016 at the age of 78.
Forouzan was popular also among the young Persians who were born after 1979 revolution.
Sahabzada Yaqub Khan
Sahabzada Yaqub Khan (23 December 1920 – 26 January 2016) was a high-profile Pakistani figure and high-ranking general. He was the most senior figure in military and government assignments in the Pakistan Government. He was born in Rampur, India.
He was an important figure in Pakistan that related to international affairs for thirty years. He served as the foreign minister under President General Zia-ul-Haq from 1982 to 1991 and as the caretaker foreign minister from 1996 to 1997. He also served as the Pakistan Ambassador of the United States serving from 1973 though 1979.
Khan died in Islamabad on 26 January 2016 at the age of 95.
Chikungunya
Chikungunya (pronounced "chicken-GUN-yay") is an infection caused by the chikungunya virus. It can cause joint pains that can last for weeks, months, or sometimes even years. About 1 in every 1000 people who gets chikungunya dies. People who are elderly or have other medical problems are most likely to die or get very sick from chikungunya.
Chikungunya is spread to humans by two species of mosquito: "Aedes albopictus" and "Aedes aegypti". These mosquitoes carry the infection to humans after biting monkeys, birds, cattle, or rodents who have chikungunya. Since 2004, there have been outbreaks (where many people get chikungunya) in Asia, Europe, and The Americas.
There is no known treatment or cure for chikungunya.
It can take one to twelve days for a person to get sick after they get the chikungunya virus. (This period of time is called the virus's incubation period.) Usually, people get sick in three to seven days. Most people who get the virus (72% to 97%) get symptoms.
Chikungunya has an "acute phase", which lasts a short time, and a "chronic phase", which can last weeks, months, or years.
The acute phase usually begins with a sudden high fever that can last up to ten days. The fever is usually above 39 °C (102 °F), and can sometimes get as high as 40 °C (104 °F). About half of people with chikungunya get a rash, usually about two to five days after symptoms start. Some people also have gastrointestinal symptoms, like abdominal pain, nausea, vomiting, or diarrhea. In rare cases, people may get conjunctivitis or other problems with their eyes.
The body starts to fight the virus after about a week by sending out immunoglobulin M (IgM), which attacks the virus. After this, most of the symptoms usually start to get better. However, people often keep having some symptoms for about another week, like headache, insomnia (trouble sleeping), and exhaustion. After these symptoms end, the acute phase of chikungunya is usually over.
In chikungunya's chronic phase, almost everyone with the virus (87% - 98%) gets very bad joint pain or stiffness. This usually lasts for weeks or months. However, it can last for years. The joint pain can be so bad that a person cannot move the joints that hurt. The pain almost always happens in more than one joint. Usually, people have pain in the joints in their arms and legs, on both sides. These may include the joints in the wrists, ankles, hands, feet, shoulders, elbows, and knees. The virus can also cause pain in the muscles or ligaments.
Sometimes, it can be difficult to tell the difference between chikungunya and dengue fever. Both infections cause some of the same symptoms, like fever and very bad pain. However, chikungunya usually does not cause bleeding. If a person diagnosed with chikungunya has bleeding problems, they may:
The best way for people to protect themselves from chikungunya is to protect themselves from mosquitoes in places where the disease is common. For example, people may use bug spray and mosquito nets, and wear long sleeves and long pants when they are outside. In places where chikungunya is common, governments can also do things to control the number of mosquitoes. For example, they can spray pesticides.
There is no vaccine for chikungunya. Scientists are doing experiments to try to make a vaccine. However, scientists say that even if they created a vaccine, people would still have to control mosquitoes to prevent chikungunya.
There is no known treatment for chikungunya. No known anti-viral medicines (medicines which kill viruses) kill the chikungunya virus.
Medical professionals can only give "supportive care." This means they can only treat chikungunya's symptoms. For example, they may treat fever and joint pain with nonsteroidal anti-inflammatory drugs (NSAIDs) like naproxen; painkillers like paracetamol (acetaminophen); and fluids. Aspirin is not given because it can make bleeding more likely to happen.
Scientists have not found any medication that helps everyone with chikungunya who has bad joint pain. There is some evidence that certain medicines may help people who have bad joint pain for more than two weeks. These medicines include:
These medicines do not help the symptoms of chikungunya during the acute phase.
About 1 in 1000 people who get chikungunya die from the disease. People older than 65, newborn babies, and people with other medical problems are most likely to have the most dangerous problems. Chikungunya is especially dangerous for newborns because they can get the virus from their mothers during childbirth, and because newborns' immune systems have to grow before they work as well as adults'. This makes it much more difficult for newborns to fight off the virus.
Elderly people, and people who already have arthritis, are more likely to have chronic joint pain.
In the past, chikungunya existed mostly in developing countries. However, more recently, there have been epidemics (where a very large number of people get the virus) in the Indian Ocean, the Pacific Islands, and the Americas.
When chikungunya was first discovered in 1952, it was uncommon and happened only in West Africa. People usually got the disease during rainy seasons, because mosquitoes are more common during these times. Beginning in the 1960s, there were sometimes outbreaks in Asia and Africa. However, until 2005, chikungunya had been uncommon throughout the world.
Since 2005, chikungunya has become much more common. It has caused large outbreaks in Africa, Asia, and the Americas. For example, in India, chikungunya re-appeared after 32 years where no Indian person had gotten the virus. Outbreaks have also happened in Europe, the Caribbean, and South America, where chikungunya had never spread before. A few people have also gotten chikungunya in the United States and Australia, where the virus had never lived before.
In 2005, there was a very large outbreak on Réunion, an island in the Indian Ocean. Out of about 770,000 people who lived on the island, about 266,000 (over 1 in every 3 people) got chikungunya. In 2006, about 1.25 million people in India got the virus.
Chikungunya was recently spread to the Americas. From 2013-2014 in the Americas, 1,118,763 people have been thought to have the virus. Of these cases, 24,682 were proven to be chikungunya.